13th Pharmacovigilance Conference, Amsterdam - Hoofdinhoud
| datum | 29 januari 2020 |
|---|---|
| plaats | Amsterdam |
| locatie | HILTON HOTEL, Amsterdam  |
| organisatie | Medicines for Europe |
Please book your accommodation by phoning +31-(0) 20-7106014 or sending an email to carlijn.swagemakers@hilton.com
ADVERTISING, EXHIBITION & SPONSORSHIP OPPORTUNITIES
Medicines for Europe Pharmacovigilance Conference
The Medicines for Europe annual Pharmacovigilance Conference is more than a traditional conference. It is a unique opportunity to learn about the latest trends, to engage with renowned experts, and to personally develop as a healthcare professional.
The 13th Pharmacovigilance Conference will take place for the very first time in Amsterdam at the Hilton Hotel on 29th January 2020.
Take the opportunity to learn from regulators and leading experts and discover what the challenges and opportunities will be in the field of Pharmacovigilance in 2020.
What can you expect from the Conference programme in 2020?
Our sessions will allow conference attendees to catch up on all recent activities and to prepare themselves for upcoming challenges and milestones such as:
-
-How globalisation is impacting pharmacovigilance
-
-The end of the signal detection pilot: what does the future hold for Marketing Authorisation Holders?
-
-Finding out about the lifecycle approach in pharmacovigilance and how it can leverage risk minimisation
-
-Measuring the impact of pharmacovigilance activities
-
-Discovering the latest trends in compliance and inspections
-
-How we can simplify and reduce burden in the pharmacovigilance system
-
-How to maximise work sharing and improve system efficiency for industry and regulators
Do not miss out on these exciting discussions. Join us to discover and learn from the experts who will be joining us in Amsterdam in 2020.
We look forward to seeing you there!
Contents
jQuery(document).ready(function($){ $("#team-8569 .team-items").owlCarousel({ items : 5, //10 items above 1000px browser width autoHeight:true, responsiveClass:true, responsive:{ 0:{ items:1, nav:true }, 600:{ items:2, nav:true }, 900:{ items:2, nav:true }, 1000:{ items:5, nav:true, } }, navText : ["",""], nav: true, }); });
Director General, Medicines for Europe
Adrian van den HovenDirector General, Medicines for Europe
Dutch Representative of the PRAC, Chair, Medicines Evaluation Board
Sabine StrausDutch Representative of the PRAC, Chair, Medicines Evaluation Board
Head Patient Safety, Sandoz International and Chair PV Working Group, Medicines for Europe
Dr. med. Sebastian HornHead Patient Safety, Sandoz International and Chair PV Working Group, Medicines for Europe
Director of Policy, European Patients' Forum (EPF)
Kaisa ImmonenDirector of Policy, European Patients' Forum (EPF)
Group Lead, Medicines Safety, WHO
Shanti PalGroup Lead, Medicines Safety, WHO
PRAC Vice Chair, BfArM
Martin HuberPRAC Vice Chair, BfArM
Head of Clinical Safety & Pharmacovigilance Biosimilars, Fresenius Kabi SwissBioSim GmbH
Uwe GudatHead of Clinical Safety & Pharmacovigilance Biosimilars, Fresenius Kabi SwissBioSim GmbH
Head of Pharmacovigilance and Epidemiology Department, European Medicines Agency (EMA)
Peter ArlettHead of Pharmacovigilance and Epidemiology Department, European Medicines Agency (EMA)
GPvP Inspector, MRHA
Sophie RadickeGPvP Inspector, MRHA
Fakhredin Sayed Tabatabaei, MD, PhD
Project Manager ePI (electronic Product Information), MEB
Fakhredin Sayed Tabatabaei, MD, PhDProject Manager ePI (electronic Product Information), MEB
European Head of PV Technology Services, IQVIA
Andrew DonaldsonEuropean Head of PV Technology Services, IQVIA
Head Global Pharmacovigilance Unit, STADA Arzneimittel AG
Andreas IwanowitschHead Global Pharmacovigilance Unit, STADA Arzneimittel AG
Head of Signal and Incident Management, Pharmacovigilance and Epidemiology Department, European Medicines Agency (EMA)
Georgy GenovHead of Signal and Incident Management, Pharmacovigilance and Epidemiology Department, European Medicines Agency (EMA)
Vice-Chairperson CMDh (NL) and CMDh Member/Senior Policy Adviser, Medicines Evaluation Board (NL)
Kora Doorduyn-van der StoepVice-Chairperson CMDh (NL) and CMDh Member/Senior Policy Adviser, Medicines Evaluation Board (NL)
Head Global PSUR & RMP Unit, Teva
Klaudija Marijanović BaraćHead Global PSUR & RMP Unit, Teva
Head of Pharmacovigilance Section, Danish Medicines Agency (DK)
Benedicte LunddahlHead of Pharmacovigilance Section, Danish Medicines Agency (DK)
Technical Director, British Generic Manufacturers Association
Paul FlemingTechnical Director, British Generic Manufacturers Association
Clinical Development and Safety Director, Medicines for Europe
Susana Almeida, PhDClinical Development and Safety Director, Medicines for Europe
TBN
See highlights from our 2019 event
Video
Photo Gallery
Press Release
To secure your place at this ‘must attend’ platform, please register now and you too can share information with leading experts and network with your peers.
Follow the event on Twitter: #PHV20
Medicines for Europe is honored to be collaborating with the following partners to make this year’s conference
M: +44 (0) 7 562 87 68 73
For more information on advertising, exhibition and sponsorship packages:
M: +31 6 4119 0824
Media Requirements and Press Policy
For any other media enquiries:
P: +32 (0)2 239 2019